Dysregulated D6D has gained interest as a novel hallmark of AD, and genetics studies reported AD patients to have a lower expression of the Fatty Acid Desaturase 2 gene, which encodes for D6D.41, 42. Here, FADS2 is linked to Alzheimer disease.